GSK Wellbutrin XL Launch Not Affected By Lost Shipment, Biovail Says
Executive Summary
GlaxoSmithKline's ongoing launch of Wellbutrin XL will not be affected by the loss of a product shipment from Biovail's manufacturing facility, Biovail assured analysts during an Oct. 3 teleconference